Maplebear (CART) vs HealthEquity (HQY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Maplebear (CART) has outperformed HealthEquity (HQY) over the past year, gaining 22.2% versus a loss of 0.2%. Maplebear is the larger company by market cap ($11.34 billion vs $7.66 billion), about 1.5 times the size. On valuation, Maplebear trades at a lower forward P/E (9.8x vs 16.8x for HealthEquity).
HealthEquity converts more of its revenue into profit, with a net margin of 16.4% versus 11.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CART | HQY |
|---|---|---|
| Share price | $47.76 | $92.61 |
| Market cap | $11.34B | $7.66B |
| 1-day change | +3.15% | -0.47% |
| YTD return | +6.18% | +1.09% |
| 1-year return | +22.18% | -0.18% |
| 5-year return | — | +46.65% |
| P/E ratio (TTM) | 25.27 | 33.43 |
| Forward P/E | 9.75 | 16.84 |
| EPS (TTM) | $1.89 | $2.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.74B | $1.31B |
| Revenue growth (YoY) | +10.78% | +9.47% |
| Net income (latest FY) | $447.00M | $215.20M |
| Gross margin | 73.70% | 69.52% |
| Operating margin | 13.31% | 24.55% |
| Net margin | 11.95% | 16.38% |
| 52-week high | $52.68 | $107.62 |
| 52-week low | $32.73 | $72.76 |
| Distance from 52-week high | -9.34% | -13.95% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +21.88% | +28.85% |
| Average volume | 4.01M | 844.82K |
| Shares outstanding | 237.33M | 82.72M |
| Employees | 3,600 | 2,814 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Business Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CART has outperformed HQY by 22.4 percentage points over the past year.
- HealthEquity trades at a higher earnings multiple (33.4x vs 25.3x trailing P/E).
About Maplebear
CART stock →Maplebear Inc., doing business as Instacart, operates as a technology and enablement partner for the grocery industry in the United States and internationally. The company offers Instacart Marketplace which helps retailers serve customers' needs by supporting fulfillment options, shopping occasions, and categories; Instacart Enterprise platform, an end-to-end technology solution for retailers across all aspects of business; and Instacart Ads, enables brands to learn more about general consumer behavior from discovery to purchase, offering insights about how to optimize advertising spend.
Consumer Discretionary · Business Services · 3,600 employees
About HealthEquity
HQY stock →HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
Consumer Discretionary · Business Services · 2,814 employees
CART vs HQY FAQ
Which is bigger, Maplebear or HealthEquity?
Maplebear (CART) is larger, with a market capitalization of $11.34B compared with $7.66B for HealthEquity (HQY).
Which stock has performed better over the past year, CART or HQY?
CART returned +22.18% over the past 12 months, compared with -0.18% for HQY (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CART or HQY?
CART has the lower trailing P/E at 25.3, versus 33.4 for HQY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Maplebear and HealthEquity in the same industry?
Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.